Wout W A van den Broek (Wout Wa van den Broek)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 13

Top Topics

Antiplatelet Therapy

Newly Diagnosed

Ejection Fraction

Acute Coronary Syndrome

Top Venues

American journal of cardiovascular drugs : drugs, devices, and other interventions

European heart journal

Journal of clinical medicine

Journal of the American Heart Association

This page only lists publications with an associated author ORCID identifier.

Publications

Wout W A van den Broek, Jurrien M Ten Berg
The puzzle of antiplatelet therapy in ACS: ticagrelor monotherapy is another missing piece. European heart journal 45 (33) (2024)
Wout W A van den Broek, Jurrien M Ten Berg
The puzzle of antiplatelet therapy in ACS: ticagrelor monotherapy is another missing piece. European heart journal 45 (33) (2024)
Wout W A van den Broek, Jurrien M Ten Berg
The puzzle of antiplatelet therapy in ACS: ticagrelor monotherapy is another missing piece. European heart journal (2024)
Wout W A van den Broek, Nabil Mani, Jaouad Azzahhafi, Jurrien M Ten Berg
CYP2C9 Polymorphisms and the Risk of Cardiovascular Events in Patients Treated with Clopidogrel: Combined Data from the POPular Genetics and POPular AGE Trials. American journal of cardiovascular drugs : drugs, devices, and other interventions (2023)
Wout W A van den Broek, Nabil Mani, Jaouad Azzahhafi, Jurrien M Ten Berg
CYP2C9 Polymorphisms and the Risk of Cardiovascular Events in Patients Treated with Clopidogrel: Combined Data from the POPular Genetics and POPular AGE Trials. American journal of cardiovascular drugs : drugs, devices, and other interventions 23 (2) (2023)
Wout W A van den Broek, Nabil Mani, Jaouad Azzahhafi, Jurrien M Ten Berg
CYP2C9 Polymorphisms and the Risk of Cardiovascular Events in Patients Treated with Clopidogrel: Combined Data from the POPular Genetics and POPular AGE Trials. American journal of cardiovascular drugs : drugs, devices, and other interventions 23 (2) (2023)
Wout W A van den Broek, Nabil Mani, Jaouad Azzahhafi, Jurrien M Ten Berg
CYP2C9 Polymorphisms and the Risk of Cardiovascular Events in Patients Treated with Clopidogrel: Combined Data from the POPular Genetics and POPular AGE Trials. American journal of cardiovascular drugs : drugs, devices, and other interventions 23 (2) (2023)
Wout W A van den Broek, Nabil Mani, Jaouad Azzahhafi, Jurrien M Ten Berg
CYP2C9 Polymorphisms and the Risk of Cardiovascular Events in Patients Treated with Clopidogrel: Combined Data from the POPular Genetics and POPular AGE Trials. American journal of cardiovascular drugs : drugs, devices, and other interventions 23 (2) (2023)
Wout W A van den Broek, Marieke E Gimbel, Dean R P P Chan Pin Yin, Jaouad Azzahhafi, Renicus S Hermanides, Craig Runnett, Robert F Storey, David Austin, Rohit Oemrawsingh, Justin Cooke, Gavin Galasko, Ronald J Walhout, Dirk A A M Schellings, Stijn L Brinckman, Hong Kie The, Martin G Stoel, Antonius A C M Heestermans, Debby Nicastia, Mireille E Emans, Arnoud W J van 't Hof, Hannes Alber, Robert Gerber, Paul F M M van Bergen, Ismail Aksoy, Abdul Nasser, Paul Knaapen, Cees-Joost Botman, Anho Liem, Johannes C Kelder, Jurriën M Ten Berg
Conservative versus Invasive Strategy in Elderly Patients with Non-ST-Elevation Myocardial Infarction: Insights from the International POPular Age Registry. Journal of clinical medicine 12 (17) (2023)
Wout W A van den Broek, Jacqueline G van Paassen, Marieke E Gimbel, Vera H M Deneer, Jurriën M Ten Berg, Rick A Vreman
Cost-effectiveness of clopidogrel versus ticagrelor in patients of 70 years or older with non-ST-elevation acute coronary syndrome. European heart journal. Cardiovascular pharmacotherapy (2022)
Anne G Raafs, Andrea Boscutti, Michiel T H M Henkens, Wout W A van den Broek, Job A J Verdonschot, Jerremy Weerts, Davide Stolfo, Vincenzo Nuzzi, Paolo Manca, Mark R Hazebroek, Christian Knackstedt, Marco Merlo, Stephane R B Heymans, Gianfranco Sinagra
Global Longitudinal Strain is Incremental to Left Ventricular Ejection Fraction for the Prediction of Outcome in Optimally Treated Dilated Cardiomyopathy Patients. Journal of the American Heart Association 11 (6) (2022)
Wout W A van den Broek, Jurriën M Ten Berg
Is a genotype-guided therapy the optimal strategy to personalize anti-thrombotic management in patients with acute coronary syndrome? European heart journal 43 (43) (2022)
Wout W A van den Broek, Jurrien M Ten Berg
Is there a benefit for CYP2C19 genotype-guided antiplatelet treatment in elderly acute coronary syndrome patients? Pharmacogenomics 22 (12) (2021)